An Open-Label Study Evaluating the Performance of the Dose Indicator in a Metered Dose Inhaler Delivering Glycopyrrolate and Formoterol Fumarate in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease

Background: GFF MDI is a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler formulated using co-suspension delivery technology. This open-label, single-arm multicenter study (NCT02268396) evaluated the accuracy, reliability, and functionality of the GFF MDI AeroCount(®) d...

Descripción completa

Detalles Bibliográficos
Autores principales: Pudi, Krishna, Feldman, Gregory, Fakih, Faisal, Mack, Peter, Maes, Andrea, Siddiqui, Shahid, St. Rose, Earl, Reisner, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354605/
https://www.ncbi.nlm.nih.gov/pubmed/30335559
http://dx.doi.org/10.1089/jamp.2018.1466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354605/
https://www.ncbi.nlm.nih.gov/pubmed/30335559
http://dx.doi.org/10.1089/jamp.2018.1466

Ejemplares similares